Nikhil T. Pradhan

Senior Counsel

Nikhil T. Pradhan

Senior Counsel

Nikhil T. Pradhan is a senior counsel and intellectual property lawyer with Foley & Lardner LLP. He is a member of the Mechanical & Electromechanical Technologies Practice and Innovative Technology Sector. Nikhil leads teams for building patent portfolios across a broad range of technologies, including energy, automotive, aerospace, computer vision, machine learning, artificial intelligence, medical device and surgical methods, and control system technologies. Nikhil provides high-level intellectual property counseling, including competitive strategy, clearance, and invalidity/noninfringement opinions. He also provides counsel for litigation, post-grant proceedings, and transactional matters, including performing due diligence and preparing licensing and development agreements.

Nikhil provides expert counsel to clients across all sectors seeking to develop and deploy AI technologies. He helps clients create and execute on comprehensive risk management frameworks to address issues from data privacy and confidentiality obligations to negotiating licenses for external AI technologies to IP protection for AI innovations.

Nikhil was a summer associate with Foley in 2013. He also served as a summer associate with Ford Motor Company in 2012.

Prior to joining Foley, Nikhil served as an intellectual property intern with the U.S. Forest Service Patent Program. He completed a judicial externship with the Wisconsin State Court of Appeals. During law school, Nikhil worked as a graduate teaching assistant for the University of Wisconsin, Madison’s Chemical Engineering Department. He holds experience as a research intern for the MIT Center for Collective Intelligence (CCI).

15 January 2025 Health Care Law Today

AI Drug Development: FDA Releases Draft Guidance

On January 6, 2025, the U.S. Food and Drug Administration released draft guidance titled Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products explaining the types of information that the agency may seek during drug evaluation.
18 December 2024 Innovative Technology Insights

AI in Drug Discovery: 2025 Outlook

Our team analyzes the trends impacting companies utilizing artificial intelligence for drug discovery.
03 October 2024 Innovative Technology Insights

I Build Generative AI Technology: Does California’s New Transparency Requirement Apply to Me?

FAQs for developers of generative AI models and applications.
14 August 2024 Manufacturing Industry Advisor

Technology Trends in Manufacturing and Associated Legal Risk Management: Driving Technological Advancement with an Ecosystem View 

The importance of building technology-driven manufacturing businesses with an ecosystem focus emerged as a critical theme for the manufacturing sector in 2024.
16 July 2024 Innovative Technology Insights

Patenting Power Plays For AI Drug Discovery

Our team analyzes the patent portfolios of leading companies to uncover trends in how innovations at the intersection of AI and drug discovery are being protected.
17 July 2024 Events

Boston Health Care AI & Technology Investor Summit

Join Endeavor Venture Funds & Foley & Lardner for an in-person and virtual gathering dedicated to advancing healthcare technology in Boston!